Elanco Animal Health CEO receives deferred stock award
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Elanco Animal Health Inc (ELAN) awarded President, CEO and director Jeffrey N. Simmons 105.5612 deferred stock units on November 13, 2026, bringing his reported direct balance to 25,847.4735 units. Each unit represents the right to receive one share of common stock or its cash equivalent. The units settle following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F1, F2 | 105.5612 | $26.78 | $3K |
Footnotes (2)
- F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Key Figures
Key Terms
Deferred stock units technical
Executive Deferral and Stock Match Plan technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many deferred stock units did ELAN CEO Jeffrey N. Simmons receive?
When do Jeffrey N. Simmons's ELAN deferred stock units settle?
AI-generated analysis. How Rhea-AI works. Not financial advice.